ERBB2 and breast cancer: Triple-negative breast cancer (TNBC), defined by the lack of the expression of the estrogen receptor, progesterone receptor, and HER2 (1, 2), represents an aggressive breast cancer subtype with poor prognosis (3) that comprises up to 20% of all breast cancer cases (3, 4).